Overview
HKPD market data
Price History
HKPD price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.00 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.27 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 8.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.31 – $2.58 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $4.6M · P/B 2.38.
Company News
Cellyan Biotechnology shares are trading lower. The company disclosed it received an additional 180-day period from the Nasdaq to regain compliance.Benzinga · Jul 17, 2026, 12:58 PM
Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 17, 2026, 8:48 AM
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What HappenedBenzinga · Jul 17, 2026, 5:36 AM
HKPD stock has given up its prior gain. Cellyan Biotechnology shares were trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.Benzinga · Jul 16, 2026, 9:29 PM
Cellyan Biotechnology shares are trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.Benzinga · Jul 16, 2026, 8:34 PM
Cellyan Biotechnology Granted 180‑Day Nasdaq Extension To Regain ComplianceBenzinga · Jul 16, 2026, 8:32 PM
12 Industrials Stocks Moving In Tuesday's Pre-Market SessionBenzinga · Jun 23, 2026, 12:10 PM
Cellyan Biotechnology Files Prospectus For $200M Mixed ShelfBenzinga · Jun 12, 2026, 8:40 PM